Switch to standard view converting cold into hot tumors by combining immunotherapies

• Autores: John B.A.G. Haanen
• Localización: Cell, ISSN 0092-8674, Vol. 170, Nº. 6, 2017, págs. 1055-1056
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In a small phase Ib study in this issue of Cell, Ribas et al. report that the combination of intralesional injection of a modified human herpes simplex virus and systemic anti-PD-1 treatment resulted in a 62% response rate in patients with metastatic melanoma, accompanied by enhanced T cell infiltration in virus-injected lesions.